Exclusive-US pharmacies, drug discounters are discussing TrumpRx role with administration

Retail pharmacies and GoodRx are in talks with the Trump administration to expand the role of TrumpRx, potentially reshaping access to prescription drug discounts.

• Retail pharmacies, alongside prescription drug savings site GoodRx, are negotiating with the Trump administration to enhance the TrumpRx initiative beyond initial direct discounts from pharmaceutical companies.
• The discussions signal a strategic shift during the presidency of Donald Trump, aiming to involve major players like Pfizer and Amgen in the TrumpRx platform for better medication access.
• The proposed expansion could significantly alter how consumers access prescription drug savings, impacting the broader pharmaceutical industry by increasing competition and transparency in medication pricing.